Conditions Presenting with Symptoms of Peripheral Arterial Disease

Aditya M. Sharma; Patrick T. Norton; Daisy Zhu

doi:10.1055/s-0034-1393963

Seminars in Interventional Radiology, Table of Contents

Semin intervent Radiol 2014; 31(04): 281-291
DOI: 10.1055/s-0034-1393963

Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Conditions Presenting with Symptoms of Peripheral Arterial Disease

Authors

Aditya M. Sharma

¹Division of Cardiovascular Medicine, University of Virginia, Charlottesville, Virginia
Patrick T. Norton

²Department of Radiology, University of Virginia, Charlottesville, Virginia
Daisy Zhu

³Medical Education, University Virginia School of Medicine, University of Virginia, Charlottesville, Virginia

Abstract

Peripheral artery disease (PAD) is estimated to affect more than 20% of people older than 65 years. The vast majority of patients with symptoms suggestive of PAD have atherosclerosis often associated with conventional vascular risk factors such as smoking, diabetes, dyslipidemia, and inflammation. A minority of people presenting with symptoms suggesting PAD have an alternative etiology. These groups of disorders are often underdiagnosed, and if diagnosed correctly the diagnosis may be delayed. Understanding these pathologies well is important, as they can be very debilitating and optimal treatment may vary significantly. Inappropriate treatment of these disorders can lead to worsening morbidity and mortality. This article discusses the underlying causes of nonatherosclerotic PAD, including the diagnosis and treatment of these disorders.

Keywords

nonatherosclerotic peripheral artery disease - mimics of peripheral vascular disease - iliac artery endofibrosis - popliteal artery entrapment syndrome - fibromuscular dysplasia - interventional radiology

Full Text

References

References
1 Olin JW, Gornik HL, Bacharach JM , et al; American Heart Association Council on Peripheral Vascular Disease; American Heart Association Council on Clinical Cardiology; American Heart Association Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation; American Heart Association Council on Cardiovascular Disease in the Young; American Heart Association Council on Cardiovascular Radiology and Intervention; American Heart Association Council on Epidemiology and Prevention; American Heart Association Council on Functional Genomics and Translational Biology; American Heart Association Council for High Blood Pressure Research; American Heart Association Council on the Kidney in Cardiovascular Disease; American Heart Association Stroke Council. Fibromuscular dysplasia: state of the science and critical unanswered questions: a scientific statement from the American Heart Association. Circulation 2014; 129 (9) 1048-1078
2 Plouin PF, Perdu J, La Batide-Alanore A, Boutouyrie P, Gimenez-Roqueplo AP, Jeunemaitre X. Fibromuscular dysplasia. Orphanet J Rare Dis 2007; 2: 28
3 Perdu J, Boutouyrie P, Bourgain C , et al. Inheritance of arterial lesions in renal fibromuscular dysplasia. J Hum Hypertens 2007; 21 (5) 393-400
4 Pannier-Moreau I, Grimbert P, Fiquet-Kempf B , et al. Possible familial origin of multifocal renal artery fibromuscular dysplasia. J Hypertens 1997; 15 (12, Pt 2) 1797-1801
5 Grimbert P, Fiquer-Kempf B, Coudol P , et al. [Genetic study of renal artery fibromuscular dysplasia]. Arch Mal Coeur Vaiss 1998; 91 (8) 1069-1071
6 Olin JW, Froehlich J, Gu X , et al. The United States Registry for Fibromuscular Dysplasia: results in the first 447 patients. Circulation 2012; 125 (25) 3182-3190
7 Harrison Jr EG, McCormack LJ. Pathologic classification of renal arterial disease in renovascular hypertension. Mayo Clin Proc 1971; 46 (3) 161-167
8 Sharma AM, Gornik HL. Standing arterial waves is NOT fibromuscular dysplasia. Circ Cardiovasc Interv 2012; 5 (1) e9-e11
9 Norton PT, Hagspiel KD. Stationary arterial waves in magnetic resonance angiography. J Vasc Interv Radiol 2005; 16 (3) 423-424
10 Paravastu SC, Regi JM, Turner DR, Gaines PA. A contemporary review of cystic adventitial disease. Vasc Endovascular Surg 2012; 46 (1) 5-14
11 Tsilimparis N, Hanack U, Yousefi S, Alevizakos P, Rückert RI. Cystic adventitial disease of the popliteal artery: an argument for the developmental theory. J Vasc Surg 2007; 45 (6) 1249-1252
12 Flanigan DP, Burnham SJ, Goodreau JJ, Bergan JJ. Summary of cases of adventitial cystic disease of the popliteal artery. Ann Surg 1979; 189 (2) 165-175
13 Levien LJ, Benn CA. Adventitial cystic disease: a unifying hypothesis. J Vasc Surg 1998; 28 (2) 193-205
14 Sharma P, Padhiar N, Kyriakides C. Popliteal cystic adventitial disease causing intermittent claudication in a young athlete: a case report. South Med J 2008; 101 (11) 1154-1156
15 Haid SP, Conn Jr J, Bergan JJ. Cystic adventitial disease of the popliteal artery. Arch Surg 1970; 101 (6) 765-770
16 Maged IM, Turba UC, Housseini AM, Kern JA, Kron IL, Hagspiel KD. High spatial resolution magnetic resonance imaging of cystic adventitial disease of the popliteal artery. J Vasc Surg 2010; 51 (2) 471-474
17 Germain DP. Ehlers-Danlos syndrome type IV. Orphanet J Rare Dis 2007; 2: 32
18 Pepin M, Schwarze U, Superti-Furga A, Byers PH. Clinical and genetic features of Ehlers-Danlos syndrome type IV, the vascular type. N Engl J Med 2000; 342 (10) 673-680
19 Beighton P, De Paepe A, Steinmann B, Tsipouras P, Wenstrup RJ ; Ehlers-Danlos National Foundation (USA) and Ehlers-Danlos Support Group (UK). Ehlers-Danlos syndromes: revised nosology, Villefranche, 1997. Am J Med Genet 1998; 77 (1) 31-37
20 Ong KT, Perdu J, De Backer J , et al. Effect of celiprolol on prevention of cardiovascular events in vascular Ehlers-Danlos syndrome: a prospective randomised, open, blinded-endpoints trial. Lancet 2010; 376 (9751) 1476-1484
21 Bergqvist D, Björck M, Wanhainen A. Treatment of vascular Ehlers-Danlos syndrome: a systematic review. Ann Surg 2013; 258 (2) 257-261
22 Loeys BL, Dietz HC, Braverman AC , et al. The revised Ghent nosology for the Marfan syndrome. J Med Genet 2010; 47 (7) 476-485
23 Loeys BL, Dietz HC. Loeys-Dietz syndrome. In: Pagon RA, Adam MP, Ardinger HH, , et al., eds. GeneReviews(R). Seattle, WA: University of Washington; 1993
24 Arslan-Kirchner M, Epplen JT, Faivre L , et al. Clinical utility gene card for: Loeys-Dietz syndrome (TGFBR1/2) and related phenotypes. Eur J Hum Genet 2011; 19 (10)
25 Lin YJ, Hwang B, Lee PC, Yang LY, Meng CC. Mid-aortic syndrome: a case report and review of the literature. Int J Cardiol 2008; 123 (3) 348-352
26 Graham LM, Zelenock GB, Erlandson EE, Coran AG, Lindenauer SM, Stanley JC. Abdominal aortic coarctation and segmental hypoplasia. Surgery 1979; 86 (4) 519-529
27 Onat T, Zeren E. Coarctation of the abdominal aorta. Review of 91 cases. Cardiologia 1969; 54 (3) 140-157
28 Stanley JC, Criado E, Eliason JL, Upchurch Jr GR, Berguer R, Rectenwald JE. Abdominal aortic coarctation: surgical treatment of 53 patients with a thoracoabdominal bypass, patch aortoplasty, or interposition aortoaortic graft. J Vasc Surg 2008; 48 (5) 1073-1082
29 Weyand CM, Goronzy JJ. Medium- and large-vessel vasculitis. N Engl J Med 2003; 349 (2) 160-169
30 Arend WP, Michel BA, Bloch DA , et al. The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum 1990; 33 (8) 1129-1134
31 Hartlage GR, Palios J, Barron BJ , et al. Multimodality imaging of aortitis. JACC Cardiovasc Imaging 2014; 7 (6) 605-619
32 Chuang VP. Radiation-induced arteritis. Semin Roentgenol 1994; 29 (1) 64-69
33 Louis EL, McLoughlin MJ, Wortzman G. Chronic damage to medium and large arteries following irradiation. J Can Assoc Radiol 1974; 25 (2) 94-104
34 Himmel PD, Hassett JM. Radiation-induced chronic arterial injury. Semin Surg Oncol 1986; 2 (4) 225-247
35 Baerlocher MO, Rajan DK, Ing DJ, Rubin BB. Primary stenting of bilateral radiation-induced external iliac stenoses. J Vasc Surg 2004; 40 (5) 1028-1031
36 Mellière D, Desgranges P, Berrahal D , et al. [Radiation-induced aorto-ilio-femoral arterial arteritis. Mediocrity of the long-term results after conventional surgery]. J Mal Vasc 2000; 25 (5) 332-335
37 Seo P, Stone JH. Large-vessel vasculitis. Arthritis Rheum 2004; 51 (1) 128-139
38 Salvarani C, Crowson CS, O'Fallon WM, Hunder GG, Gabriel SE. Reappraisal of the epidemiology of giant cell arteritis in Olmsted County, Minnesota, over a fifty-year period. Arthritis Rheum 2004; 51 (2) 264-268
39 Kermani TA, Matteson EL, Hunder GG, Warrington KJ. Symptomatic lower extremity vasculitis in giant cell arteritis: a case series. J Rheumatol 2009; 36 (10) 2277-2283
40 Saleh Z, Arayssi T. Update on the therapy of Behçet disease. Ther Adv Chronic Dis 2014; 5 (3) 112-134
41 Dalvi SR, Yildirim R, Yazici Y. Behcet's syndrome. Drugs 2012; 72 (17) 2223-2241
42 Saadoun D, Lambert M, Mirault T , et al. Retrospective analysis of surgery versus endovascular intervention in Takayasu arteritis: a multicenter experience. Circulation 2012; 125 (6) 813-819
43 Olin JW. Thromboangiitis obliterans (Buerger's disease). N Engl J Med 2000; 343 (12) 864-869
44 Mills Sr JL. Buerger's disease in the 21st century: diagnosis, clinical features, and therapy. Semin Vasc Surg 2003; 16 (3) 179-189
45 Olin JW, Shih A. Thromboangiitis obliterans (Buerger's disease). Curr Opin Rheumatol 2006; 18 (1) 18-24
46 Makita S, Nakamura M, Murakami H, Komoda K, Kawazoe K, Hiramori K. Impaired endothelium-dependent vasorelaxation in peripheral vasculature of patients with thromboangiitis obliterans (Buerger's disease). Circulation 1996; 94 (9, Suppl): II211-II215
47 Piazza G, Creager MA. Thromboangiitis obliterans. Circulation 2010; 121 (16) 1858-1861
48 Cooper LT, Tse TS, Mikhail MA, McBane RD, Stanson AW, Ballman KV. Long-term survival and amputation risk in thromboangiitis obliterans (Buerger's disease). J Am Coll Cardiol 2004; 44 (12) 2410-2411
49 Fiessinger JN, Schäfer M. Trial of iloprost versus aspirin treatment for critical limb ischaemia of thromboangiitis obliterans. The TAO Study. Lancet 1990; 335 (8689) 555-557
50 Swigris JJ, Olin JW, Mekhail NA. Implantable spinal cord stimulator to treat the ischemic manifestations of thromboangiitis obliterans (Buerger's disease). J Vasc Surg 1999; 29 (5) 928-935
51 Donas KP, Schulte S, Ktenidis K, Horsch S. The role of epidural spinal cord stimulation in the treatment of Buerger's disease. J Vasc Surg 2005; 41 (5) 830-836
52 Peach G, Schep G, Palfreeman R, Beard JD, Thompson MM, Hinchliffe RJ. Endofibrosis and kinking of the iliac arteries in athletes: a systematic review. Eur J Vasc Endovasc Surg 2012; 43 (2) 208-217
53 Schep G, Bender MH, van de Tempel G, Wijn PF, de Vries WR, Eikelboom BC. Detection and treatment of claudication due to functional iliac obstruction in top endurance athletes: a prospective study. Lancet 2002; 359 (9305) 466-473
54 Falor AE, Zobel M, de Virgilio C. External iliac artery fibrosis in endurance athletes successfully treated with bypass grafting. Ann Vasc Surg 2013; 27 (8) e1-e4
55 Giannoukas AD, Berczi V, Anoop U, Cleveland TJ, Beard JD, Gaines PA. Endofibrosis of iliac arteries in high-performance athletes: diagnostic approach and minimally invasive endovascular treatment. Cardiovasc Intervent Radiol 2006; 29 (5) 866-869
56 Flors L, Leiva-Salinas C, Bozlar U , et al. Imaging evaluation of flow limitations in the iliac arteries in endurance athletes: diagnosis and treatment follow-up. AJR Am J Roentgenol 2011; 197 (5) W948-55
57 Politano AD, Tracci MC, Gupta N, Hagspiel KD, Angle JF, Cherry KJ. Results of external iliac artery reconstruction in avid cyclists. J Vasc Surg 2012; 55 (5) 1338-1344 , discussion 1344–1345
58 Sinha S, Houghton J, Holt PJ, Thompson MM, Loftus IM, Hinchliffe RJ. Popliteal entrapment syndrome. J Vasc Surg 2012; 55 (1) 252-262 , e30
59 di Marzo L, Cavallaro A. Popliteal vascular entrapment. World J Surg 2005; 29 (Suppl. 01) S43-S45
60 Kim SY, Min SK, Ahn S, Min SI, Ha J, Kim SJ. Long-term outcomes after revascularization for advanced popliteal artery entrapment syndrome with segmental arterial occlusion. J Vasc Surg 2012; 55 (1) 90-97
61 Levien LJ, Veller MG. Popliteal artery entrapment syndrome: more common than previously recognized. J Vasc Surg 1999; 30 (4) 587-598
62 Kim DI, Kim HJ, Shin C, Lee KS. An abnormal muscle in the superficial region of the popliteal fossa. Anat Sci Int 2009; 84 (1–2) 61-63
63 Chan MY, Becker RC. Identification and treatment of arterial thrombophilia. Curr Treat Options Cardiovasc Med 2008; 10 (1) 3-11
64 Delis KT, Bountouroglou D, Mansfield AO. Venous claudication in iliofemoral thrombosis: long-term effects on venous hemodynamics, clinical status, and quality of life. Ann Surg 2004; 239 (1) 118-126
65 Hunder GG, Bloch DA, Michel BA , et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 1990; 33 (8) 1122-1128